Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure

Back

ESC Professional Premium Access

Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure

Session: Young Investigator Awards Session in Thrombosis

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Speaker: Doctor P. Guedeney (Paris, FR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Paul Guedeney

Pitie Salpetriere APHP University Hospital, Paris (France)

0 follower

3 more presentations in this session

Interleukin 37 attenuates platelet activation and thrombosis formation

Speaker: Miss W. Gao (Shanghai, CN)

Large-scale lipidomics profiling reveals characteristic lipid signatures associated with an increased cardiovascular risk

Speaker: Doctor T. Harm (Tuebingen, DE)

Timing on patent foramen ovale closure: early versus delayed closure

Speaker: Doctor A. Jeronimo (Madrid, ES)

Access the full session

Young Investigator Awards Session in Thrombosis

Speakers: Doctor P. Guedeney, Miss W. Gao, Doctor T. Harm, Doctor A. Jeronimo

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure

About the speaker

Doctor Paul Guedeney

3 more presentations in this session

Interleukin 37 attenuates platelet activation and thrombosis formation

Large-scale lipidomics profiling reveals characteristic lipid signatures associated with an increased cardiovascular risk

Timing on patent foramen ovale closure: early versus delayed closure

Access the full session

Young Investigator Awards Session in Thrombosis

About the event

ESC Congress 2023

ESC 365 is supported by